Dr. Robert M. Weinrieb, MD

Dr. Weinrieb practices at Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr) in Philadelphia, Pennsylvania.

Dr. Weinrieb's NPI, 1750318671, was assigned on June 27, 2006. Dr. Weinrieb graduated from State University of New York at Buffalo School of Medicine in 1987. Dr. Weinrieb holds Pennsylvania license MD044778L.

Dr. Weinrieb's primary practice is Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr), at 3400 Spruce Street, White Bldg 1st Flr, Philadelphia, PA 19104.

Dr. Weinrieb's primary practice is Good Shepherd Penn Partners - HOPD (3400 Spruce Street, White Bldg 1st Flr) in Philadelphia, Pennsylvania. Dr. Weinrieb is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Weinrieb to 1 more group practice or clinic, named with a free account. Dr. Weinrieb's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weinrieb practices, 3 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Weinrieb's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Weinrieb is licensed in Pennsylvania.

CMS data shows 52 Medicare services from Dr. Weinrieb across 2 procedure codes in 2024, all of them office visits, for 31 Medicare patients. Medicare paid $4,688 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 31 Medicare patients who saw Dr. Weinrieb in 2024. The largest group is under 65, with 16 patients. 75% of them have anxiety, and 74% have high blood pressure. Their average risk score is 3.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Weinrieb's median patient age at 48, with 39% women.

In 2024, Dr. Weinrieb wrote 315 Medicare Part D claims for 44 patients. 93% of them were for generic drugs. CMS names the drug for 140 of them, across 7 drugs with 11 or more claims each, at $2,211 in total drug cost. In 2023, CMS named 246 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Weinrieb for performance year 2024, reported as part of a group. Dr. Weinrieb accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Weinrieb as offering telehealth.

Dmand AI links 19 papers to Dr. Weinrieb, published from 2010 to 2024. 2019 was the busiest year, with 2. The most frequent topics are Liver Transplantation, Alcoholism and Living Donors. Dr. Weinrieb has published most often in Am J Transplant. Dr. Weinrieb's most frequent co-authors are Marina Serper, MD, Ethan Michael Weinberg and Peter Lawrence Abt, MD.

Dr. Weinrieb graduated from State University of New York at Buffalo School of Medicine in 1987.